Edition:
United Kingdom

People: Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

5.29HKD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
HK$5.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
71,507,383
52-wk High
HK$13.93
52-wk Low
HK$5.09

Tse, Ping 

Mr. Tse Ping serves as Chief Executive Officer, Executive Director of the Company. He is responsible for the overall operations of the Group. With more than 25 years of extensive experience in investment and management in the pharmaceutical industry in China, he is currently a director of CT Tianqing, NJCTT, Jiangsu CT Fenghai, Jiangsu CT Qingjiang, Qingdao CT, and Beijing Tide. He is also a director of Shanghai Fortune World Development Co., Ltd., Tianjin Chiatai Feed Tech Co., Ltd., SYN Energy Technology Co., Ltd. and Chia Tai Oversea Chinese Realty Development Co., Ltd., and a non- executive director of Tianjin Binhai Teda Logistics (Group) Corporation Limited, the shares of which are listed on GEM Board of the Stock Exchange. Mr. Tse still acts as a director of Chia Tai Qingchunbao Pharmaceutical Co., Ltd. and a council member of the Association of Pharmaceutical Biotechnology of China.

Basic Compensation

Total Annual Compensation, HKD 36,727,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD --
Fiscal Year Total, HKD 36,727,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Y Y Tse

8,870,000

Ping Tse

36,727,000

Cheung Ling Cheng

11,116,000

Minggang Wang

--

Chun Ling Li

--

Hsin Tse

2,180,000
As Of  31 Dec 2017